Drug Discovery

Nominations are now open for The Medicine Maker 2021 Power List.

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.

A breakthrough in transgenic mice opens the door to “Humabodies.”

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.

The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies.

Acetaminophen derivatives could offer patients a safer alternative to common pain management treatments.

How can companies be encouraged to develop treatments for the growing number of patients living with CNS disorders?

Can a medieval medicament find use as a modern antibacterial?

Harnessing the potential of microphysiological systems to advance drug discovery.

Solving a decades-old mystery, researchers have discovered how non-ribosomal peptide synthetases work.